Fiducial Markers Market Size, Industry Analysis, Share, Growth, Key Trends and Forecast to 2032

PRESS RELEASE

Published July 6, 2023

The global fiducial markers market size was USD 120.9 Million in 2022 and is expected to register a revenue CAGR of 2.9% during the forecast period, according to the latest analysis by Emergen Research. Increasing prevalence of cancer is a key factor driving revenue growth of the market. According to the Cancer.net in the U.S., head, and neck cancer accounts for around 4% of all cancers. Head and neck cancer will be diagnosed in 66,920 people (49,190 men and 17,730 women) in 2023. In 2020, an estimated 562,328 persons will be diagnosed with head and neck cancer worldwide. It is anticipated that 15,400 people would die from head and neck cancer in the U.S. in 2023 (11,210 males and 4,190 women). An estimated 277,597 individuals died from the disease across the globe in 2020.

However, complications with the product implantation and use could restrain revenue growth of the market. Fiducial markers inserted in the lung may cause pneumothorax, or collapsed lung, a condition in which air becomes trapped between the lung and the chest wall. A chest tube may be needed to remove the air pocket and re-expand the lung in this case. Fiducial markers could migrate away from their original location. There must be enough time between marker implantation and treatment for the markers to stabilize. Infection is a concern with any surgery that enters the skin. The likelihood of an infection necessitating antibiotic therapy appears to be less than one in 1,000.

To learn about additional key drivers, trends, and challenges – Read our Sample Report right now @ https://www.emergenresearch.com/request-sample/2002

Another major market driver is technology developments in medical imaging and radiation therapy systems. The advancement of advanced imaging modalities, such as cone-beam CT and real-time MRI, has enhanced the visualisation and tracking of fiducial markers dramatically. These technical advances have resulted in better treatment outcomes, fewer side effects, and a more pleasant patient experience. Furthermore, the incorporation of fiducial markers into navigation systems and robotic-assisted surgeries has broadened their uses, propelling market growth.

However, there are several constraints in the fiducial markers industry. One of the most significant issues is the high expense of fiducial marker implantation and imaging operations. The expenditures of obtaining the markers, doing imaging scans, and executing image-guided treatments might be significant, restricting their use in some healthcare settings. Furthermore, in some places, a lack of reimbursement rules for fiducial marker-based operations can stifle market growth. Addressing these cost-related concerns, as well as expanding payment coverage, will be critical in driving greater market adoption.

Despite the obstacles, various growth factors are propelling the fiducial markers market forward. The expanding emphasis on personalised medicine and the increased need for targeted medicines are opening up new potential for the use of fiducial markers. These markers enable exact localisation and treatment delivery, allowing patients to get personalised and customised care. Furthermore, the growing elderly population and, as a result, the incidence of chronic diseases is likely to boost market expansion. As the demand for radiation therapy and image-guided procedures continues to rise, so will the demand for fiducial markers.
Some major companies in the market report include:

Medtronic plc, Boston Scientific Corporation, CIVCO Medical Solutions, IZI Medical Products, IBA, Nanovi A/S, Eckert & Ziegler, Naslund Medical AB, QLRAD, and Stellar Medical.

To learn more details about the Global Structural Heart Devices Market report, visit @ https://www.emergenresearch.com/industry-report/fiducial-markers-market

CIVCO radiation: CIVCO Radiotherapy is a major manufacturer of radiation positioning and immobilisation products, including fiducial markers. The company provides a diverse range of fiducial markers, such as gold markers, carbon markers, and electromagnetic markers. CIVCO Radiotherapy places a premium on product quality, accuracy, and interoperability with a wide range of imaging modalities.

Boston Scientific Corporation is a multinational medical technology firm that provides a variety of healthcare products, including fiducial markers. Fiducial markers from the company are intended to give great visibility, accurate localisation, and interoperability with imaging equipment. Boston Scientific focuses on creating markers that are easy to put and improve procedural efficiency.

Eckert & Ziegler BEBIG is a prominent supplier of brachytherapy supplies and solutions, including fiducial markers. The company provides a broad range of fiducial markers for precise tumour localization in radiation therapy. Eckert & Ziegler BEBIG places a premium on product quality, stability, and interoperability with various imaging modalities.

Naslund Medical AB specialises in the development and manufacture of fiducial markers for a variety of medical applications. The company provides a variety of fiducial markers, including gold and silver markers, that are highly visible and compatible with imaging equipment. Naslund Medical focuses on providing high-quality markers that are tailored to the specific requirements of healthcare professionals.

Some Significant Report Highlights:

The metal-based segment accounted for significant revenue share in the global fiducial markers market in 2022. Use of gold fiducial markers aids in the delivery of correct radiation therapy to prostate cancer patients. The technique is advised for individuals with moderate to low risk prostate cancer. The Gold Anchor, which is a novel fiducial marker, allows for faster and more effective radiation therapy treatment while also increasing patient safety. The Gold Anchor marker’s distinctive design makes it simple to implant. The fine 25G, 22G, or 20G needle reduces the danger of infection and bleeding, reduces pneumothorax and patient pain, and allows passage into nearly any interior organ.
The ultrasound segment revenue is expected to register largest revenue share in 2022. The use of Endoscopic Ultrasonography (EUS) to guide fiducial marker placement for Image-guided Radiation Therapy (IGRT) is becoming more common. Fiducial markers can be used during various image guided procedures, such as biopsies or ablation therapies. Ultrasound can help visualize the markers in real time, assisting the medical professional in accurately guiding the instruments to the desired location.
The market in North America is expected to account for largest revenue share over the forecast period. Increasing prevalence of cancer and presence of major key players in the region such as Medtronic plc., Boston Scientific Corporation, CIVCO Medical Solutions, and others in the region is also driving revenue growth of the market.

Request a discounted copy of report @ https://www.emergenresearch.com/request-discount/2002

Segmental Analysis:

Emergen Research has segmented the global fiducial markers market has segmented the global fiducial markers market on the basis of products, modality, application, end-use, and region:

Products Outlook (Revenue, USD Million; 2019-2032)

Metal Based
Pure Gold
Gold Alloys
Other Metals
Polymer Based
Others

Modality Outlook (Revenue, USD Million; 2019-2032)

CT/CBCT
Ultrasound
MRI
X-Ray

Application Outlook (Revenue, USD Million; 2019-2032)

Breast Cancer
Lung Cancer
Prostate Cancer
Head and Neck Cancer
Gastric Cancer
Others

End-use Outlook (Revenue, USD Million; 2019-2032)

Hospitals and Clinics
Radiotherapy Centers
Academic and Cancer Research Centers

Regional Outlook:

North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Buy this report at an exclusively discounted rate @ https://www.emergenresearch.com/select-license/2002

Thank you for reading our report. Customization of the report is available according to the requirements of clients. In case of further queries about the report, do get in touch with us. Our team will make sure your report is tailored according to your needs.

About Us:

Emergen Research is a market research and consulting company that provides syndicated research reports, customized r esearch reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the

Latest Published Reports by Emergen Research:

airborne lidar market

https://www.emergenresearch.com/industry-report/airborne-lidar-market

hydralazine market

https://www.emergenresearch.com/industry-report/hydralazine-market

https://www.blogger.com/profile/05862419503289705110

construction sealants market

https://www.emergenresearch.com/industry-report/construction-sealants-market

ai-enabled medical imaging solutions market

https://www.emergenresearch.com/industry-report/ai-enabled-medical-imaging-solutions-market

gerd drugs and devices market

https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market